Zobrazeno 1 - 10
of 154
pro vyhledávání: '"A, Jefremow"'
Autor:
Thoma, Oana-Maria, Naschberger, Elisabeth, Kubánková, Markéta, Larafa, Imen, Kramer, Viktoria, Menchicchi, Bianca, Merkel, Susanne, Britzen-Laurent, Nathalie, Jefremow, André, Grützmann, Robert, Koop, Kristina, Neufert, Clemens, Atreya, Raja, Guck, Jochen, Stürzl, Michael, Neurath, Markus F., Waldner, Maximilian J.
Publikováno v:
In Gastroenterology February 2024 166(2):284-297
Publikováno v:
Античный мир и археология, Vol 21, Iss 21, Pp 281-336 (2023)
In the article are collected in the form of a corpus the stamps of the initial period of the systematic marking of amphorae in Knidos - stamps with a “prora” or “ship bow” (chronological group Ib). A total of 323 stamps originating from the t
Externí odkaz:
https://doaj.org/article/7de89712ce334e1099499fff11817602
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
de Castro, Tiago, Welland, Sabrina, Jochheim, Leonie, Leyh, Cathrine, Shmanko, Kateryna, Finkelmeier, Fabian, Jeliazkova, Petia, Jefremow, Andre, Gonzalez-Carmona, Maria A., Kandulski, Arne, Roessler, Daniel, Khaled, Najib Ben, Enssle, Stefan, Venerito, Marino, Fründt, Thorben W., Schultheiß, Michael, Djanani, Angela, Pangerl, Maria, Maieron, Andreas, Wirth, Thomas C.
Publikováno v:
Hepatology Communications; Nov2024, Vol. 8 Issue 11, p1-17, 17p
Publikováno v:
Античный мир и археология, Vol 20, Iss 20, Pp 368-388 (2022)
The article publishes a fragment of a stamped Roman mortarius, accidentally found during construction work in Kerch (antique Panticapaeum). Inspite of all the ordinariness of the stamp, this mark is a unique find for the European Bosporus. The record
Externí odkaz:
https://doaj.org/article/ce57dc15775d4d25bdbbd0c24a083aa8
Autor:
Jefremow, André1,2,3 (AUTHOR) andre.jefremow@uk-erlangen.de, Neurath, Markus F.1,2,3 (AUTHOR)
Publikováno v:
Cells (2073-4409). Jul2023, Vol. 12 Issue 13, p1730. 12p.
Autor:
Rimini, M., Kudo, M., Tada, T., Shigeo, S., Kang, W., Suda, G., Jefremow, A., Burgio, V., Iavarone, M., Tortora, R., Marra, F., Lonardi, S., Tamburini, E., Piscaglia, F., Masi, G., Cabibbo, G., Foschi, F.G., Silletta, M., Kumada, T., Iwamoto, H., Aoki, T., Goh, M.J., Sakamoto, N., Siebler, J., Hiraoka, A., Niizeki, T., Ueshima, K., Sho, T., Atsukawa, M., Hirooka, M., Tsuji, K., Ishikawa, T., Takaguchi, K., Kariyama, K., Itobayashi, E., Tajiri, K., Shimada, N., Shibata, H., Ochi, H., Yasuda, S., Toyoda, H., Fukunishi, S., Ohama, H., Kawata, K., Tani, J., Nakamura, S., Nouso, K., Tsutsui, A., Nagano, T., Takaaki, T., Itokawa, N., Okubo, T., Arai, T., Imai, M., Joko, K., Koizumi, Y., Hiasa, Y., Cucchetti, A., Ratti, F., Aldrighetti, L., Cascinu, S., Casadei-Gardini, A.
Publikováno v:
In ESMO Open December 2021 6(6)
Autor:
Jefremow, André, Neurath, Markus F.
Publikováno v:
In Best Practice & Research Clinical Gastroenterology October-December 2021 54-55
Autor:
Andrea Casadei-Gardini, Margherita Rimini, Masatoshi Kudo, Shigeo Shimose, Toshifumi Tada, Goki Suda, Myung Ji Goh, Andre Jefremow, Mario Scartozzi, Giuseppe Cabibbo, Claudia Campani, Emiliano Tamburini, Francesco Tovoli, Kazuomi Ueshima, Tomoko Aoki, Hideki Iwamoto, Takuji Torimura, Takashi Kumada, Atsushi Hiraoka, Masanori Atsukawa, Ei Itobayashi, Hidenori Toyoda, Naoya Sakamoto, Takuya Sho, Wonseok Kang, Jürgen Siebler, Markus Friedrich Neurath, Valentina Burgio, Stefano Cascinu
Publikováno v:
Liver Cancer (2022)
Introduction: In the REFLECT trial, lenvatinib was found to be non-inferior compared to sorafenib in terms of Overall Survival. Here, we analyze the effects of lenvatinib in the real-life experience of several centers across the world, and to identif
Externí odkaz:
https://doaj.org/article/08c68969bf5f4251a200dc0cdcbbbea5
Autor:
André Jefremow, Markus F. Neurath
Publikováno v:
Cells, Vol 12, Iss 13, p 1730 (2023)
Biologicals have dominated the therapeutic scenery in inflammatory bowel diseases (IBDs), namely ulcerative colitis (UC) and Crohn’s disease (CD), for the past 20 years. The development of tofacitinib was the starting point for an era of small mole
Externí odkaz:
https://doaj.org/article/a012031b37874bdf853a7f6a9e794ae9